Man Group PLC I Bio, Inc. Transaction History

Man Group PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.3 - $0.61 $62,318 - $126,714	-207,729 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.06 - $1.52 $79,500 - $114,000	75,000 Added 56.51%	207,729 $220,000
Q2 2021 Aug 16, 2021	BUY	$1.22 - $1.65 $161,929 - $219,002	132,729 New	132,729 $200,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $23.7M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.